SEC Stock Data Quick Answer Zevia PBC reported Total Revenue of $161.26 million for fiscal year 2025. Zevia PBC Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $161.26M +4.0% 2024 $155.05M -6.8% 2023 $166.42M +2.0% 2022 $163.18M +18.1% 2021 $138.17M +25.6% 2020 $110.03M — Quarterly Total Revenue Quarter Ending Total Revenue YoY QoQ September … Read more
Quick Answer Zevia PBC reported Total Revenue of $161.26 million for fiscal year 2025. Zevia PBC — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $161.26M+4.0% $155.05M-6.8% $166.42M+2.0% $163.18M+18.1% $138.17M+25.6% $110.03M Net Income -$9.92M+50.4% -$20.00M — -$47.65M+45.7% -$87.67M-1344.0% -$6.07M Diluted EPS -$0.15+55.9% -$0.34+17.1% -$0.41+49.4% -$0.81+39.1% -$1.33 — Total Assets $63.62M-6.4% … Read more
Quick Answer Zura Bio Ltd reported Shares Outstanding of 73.68 million shares for fiscal year 2025. Zura Bio Ltd Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 73.68M +12.8% 2024 65.30M +49.8% 2023 43.59M +15484.8% 2022 279,720 — Quarterly Shares Outstanding Quarter Ending Shares Outstanding YoY QoQ September 30, 2025 65.02M … Read more
Quick Answer Zura Bio Ltd reported Operating Income of -$75.25 million for fiscal year 2025. Zura Bio Ltd Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 -$75.25M -36.3% 2024 -$55.19M +11.9% 2023 -$62.64M -130.6% 2022 -$27.16M — Quarterly Operating Income Quarter Ending Operating Income YoY QoQ September 30, 2025 -$19.52M -1.0% … Read more
Quick Answer Zura Bio Ltd reported R&D Expense of $42.08 million for fiscal year 2025. Zura Bio Ltd R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2025 $42.08M +72.5% 2024 $24.40M -44.5% 2023 $44.00M +85.7% 2022 $23.69M — Quarterly R&D Expense Quarter Ending R&D Expense YoY QoQ September 30, 2025 $11.95M +98.2% … Read more
Quick Answer Zura Bio Ltd reported Stockholders Equity of $101.54 million for fiscal year 2025. Zura Bio Ltd Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $101.54M -30.8% 2024 $146.81M +147.5% 2023 $59.33M +285.1% 2022 -$32.06M -249.2% 2021 -$9.18M — 2021 $0.00 — Quarterly Stockholders Equity Quarter Ending Stockholders Equity YoY … Read more
Quick Answer Zura Bio Ltd reported Cash and Equivalents of $109.41 million for fiscal year 2025. Zura Bio Ltd Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $109.41M -38.0% 2024 $176.50M +76.8% 2023 $99.81M +723918.9% 2022 $13.8K -98.1% 2021 $729.2K — Quarterly Cash and Equivalents Quarter Ending Cash and … Read more
Quick Answer Zura Bio Ltd reported Total Assets of $113.95 million for fiscal year 2025. Zura Bio Ltd Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $113.95M -36.5% 2024 $179.53M +78.0% 2023 $100.84M +1816.4% 2022 $5.26M -96.3% 2021 $140.55M — Quarterly Total Assets Quarter Ending Total Assets YoY QoQ September 30, … Read more
Quick Answer Zura Bio Ltd reported Diluted EPS of $1.06 per share (loss) for fiscal year 2025. Zura Bio Ltd Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 -$1.06 -76.7% 2024 -$0.60 +71.3% 2023 -$2.09 +98.5% 2022 -$141.97 — Quarterly Diluted EPS Quarter Ending Diluted EPS YoY QoQ September 30, 2025 … Read more
Quick Answer Zura Bio Ltd reported Net Income of -$68.65 million for fiscal year 2025. Zura Bio Ltd Net Income — Annual History Fiscal Year Net Income YoY Change 2025 -$68.65M -31.0% 2024 -$52.40M +13.2% 2023 -$60.36M -134.5% 2022 -$25.74M — Quarterly Net Income Quarter Ending Net Income YoY QoQ September 30, 2025 -$18.04M +12.9% … Read more